BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 16721048)

  • 1. Absolute quantification of somatic DNA alterations in human cancer.
    Carter SL; Cibulskis K; Helman E; McKenna A; Shen H; Zack T; Laird PW; Onofrio RC; Winckler W; Weir BA; Beroukhim R; Pellman D; Levine DA; Lander ES; Meyerson M; Getz G
    Nat Biotechnol; 2012 May; 30(5):413-21. PubMed ID: 22544022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Convergent TP53 loss and evolvability in cancer.
    Mansur MB; Greaves M
    BMC Ecol Evol; 2023 Sep; 23(1):54. PubMed ID: 37743495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent somatic evolution commences in utero in a germline ribosomopathy.
    Machado HE; Øbro NF; Williams N; Tan S; Boukerrou AZ; Davies M; Belmonte M; Mitchell E; Baxter EJ; Mende N; Clay A; Ancliff P; Köglmeier J; Killick SB; Kulasekararaj A; Meyer S; Laurenti E; Campbell PJ; Kent DG; Nangalia J; Warren AJ
    Nat Commun; 2023 Aug; 14(1):5092. PubMed ID: 37608017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLL3 is a de novo cause of endocrine therapy resistance.
    Stauffer KM; Elion DL; Cook RS; Stricker T
    Cancer Med; 2021 Nov; 10(21):7692-7711. PubMed ID: 34581028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAP Kinases Pathways in Gastric Cancer.
    Magnelli L; Schiavone N; Staderini F; Biagioni A; Papucci L
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-802 plays a tumour suppressive role in tongue squamous cell carcinoma through directly targeting MAP2K4.
    Wu X; Gong Z; Sun L; Ma L; Wang Q
    Cell Prolif; 2017 Jun; 50(3):. PubMed ID: 28319306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic targeting of B-RafV600E affects survival and proliferation and identifies selective agents against BRAF-mutant colorectal cancer cells.
    Hirschi B; Gallmeier E; Ziesch A; Marschall M; Kolligs FT
    Mol Cancer; 2014 May; 13():122. PubMed ID: 24885690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MKK4 as oncogene or tumor suppressor: in cancer and senescence, the story's getting old.
    Cunningham SC; Gallmeier E; Kern SE
    Aging (Albany NY); 2010 Nov; 2(11):752-3. PubMed ID: 21084726
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular diagnostics of CNS embryonal tumors.
    Pfister SM; Korshunov A; Kool M; Hasselblatt M; Eberhart C; Taylor MD
    Acta Neuropathol; 2010 Nov; 120(5):553-66. PubMed ID: 20882288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V; Leprince D
    Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
    Gao X; Porter AT; Honn KV
    Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theoretical proposal: allele dosage of MAP2K4/MKK4 could rationalize frequent 17p loss in diverse human cancers.
    Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Abdelmohsen K; Gorospe M; Kern SE
    Cell Cycle; 2006 May; 5(10):1090-3. PubMed ID: 16721048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma.
    Chae KS; Ryu BK; Lee MG; Byun DS; Chi SG
    Eur J Cancer; 2002 Oct; 38(15):2048-57. PubMed ID: 12376211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
    Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Calhoun ES; Falco G; Abdelmohsen K; Gorospe M; Kern SE
    Cancer Res; 2006 Jun; 66(11):5560-4. PubMed ID: 16740690
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.